Cannabis Science Developing Various Cannabis Strains for Future Drug Development

Today, US-based Cannabis Science, Inc. announced that it has started production of several strains of cannabis and European Union certified hemp varieties to start scientific research to pick the best strains for development of proprietary formulations for clinical drug development.

Cannabis Science, a company specializing in cannabis formulation-based drug development and related consulting, said that it has started producing the various strains of cannabis and hemp varieties to conduct research to select those that are best for drug development, in order to bring cannabis formulations to the market for patients with critical illnesses, such as cancer and neurological disorders.

“Cannabis Science intends to leverage its team’s expertise to create a framework for research and clinical testing. We are excited to report further development and progress as we proceed forward,” said Mr. Mario S. Lap, Director and President of European Operations.

The facilities are located in the Alicante region of Spain. According to Cannabis Science, it is working with a local partner to initiate an agricultural program to prepare GMP production and to start building the research framework in order to conduct scientific testing of extracts and the active components contained in the cannabis plant with the objective of developing selected formulations for clinical use.

According to the company, its immediate focus is to treat cancer, which Cannabis Science considers to be one of the most important diseases in the world. In 2013, the company submitted patent application N2010968 in Europe entitled “Composition for the Treatment of Neurobehavioral Disorders.” The patent is for development of cannabinoid-based formulations to treat several neurobehavioral disorders, such as attention deficit hyperactivity disorder (ADHD) and anxiety. The first formulation in the series of products targeting neurobehavioral disorders is the pre-clinical development and use of the invention in food products through a licensing agreement with partner company OmniCanna Health Solutions.

Source: Cannabis Science, Inc.

Last updated: 7/31/14; 2:55pm EST